imported 2024-03-17 17:43:08
G茅rard Mangoua dresse un bilan du secteur de la distribution de m茅dicaments en Afrique, et nous parle des d茅fis qu’il doit surmonter en tant que Directeur G茅n茅ral d’Ubipharm et PDG de Planet Pharma, mais aussi de ses avantages concurrentiels. Il 茅voque 茅galement ses priorit茅s du moment et partage sa vision pour le futur du secteur et de ses activit茅s.
G茅rard Mangoua, Directeur G茅n茅ral d’Ubipharm et PDG de Planet Pharma, explique quels sont ses avantages concurrentiels par rapport 脿 d’autres acteurs de la distribution de m茅dicaments.
Ibrahim Diawara explique comment le secteur pharmaceutique s鈥檈st d茅velopp茅 au cours des deux derni猫res ann茅es en C么te d’Ivoire et 茅voque la n茅cessit茅 de mettre en place une politique protectionniste. Il parle 茅galement des derni猫res r茅alisations de Cipharm et partage sa vision pour le futur.
Ibrahim Diawara, Pr茅sident Directeur G茅n茅ral de Cipharm, explique quelles ont 茅t茅 les r茅alisations majeures du groupe ces derni猫res ann茅es, ainsi que les avantages concurrentiels de Cipharm sur le march茅 pharmaceutique en C么te d’Ivoire.
Abdullahi Ali, Chairman and CEO of Simba Investments and Member of the Somalia National Alliance Party (SNAP), talks about investments and gives an overview of Kenya and Somalia.
It鈥檚 very clear that the family business in Saudi Arabia is dominant in general for the economy. The future of the family business has to be improved and developed to meet the challenges, which is technology and many other things.
Khalid Abdul-Latif Youssef is executive manager of Jamjoom Pharma talks about the pharmaceutical industry in Saudi Arabia and Jamjoom Pharma — one of the leading pharmaceutical companies in Saudi Arabia.
In addition, according to Ninth Development Plan by Ministry of Economic & Planning, increasing life expectancy (74 years) which is leading to an ageing population in need for specific and costly health services (> 60 years are growing from 4% to 7% in 2020).
Our group has been in the pharma industry for more than 25 years. We have been quite successful. We have partners who have contributed a lot to the pharma industry. In 2014, our turnover was almost SAR 2 billion. Recently we realized there was a need in the market, and among our partners, for local manufacturing.
Jamjoom Medicine was established more than 55 years ago. It has been one of the major players in the healthcare industry. Jamjoom Medicine was the first member of the Jamjoom Pharmaceutical Group. Our strategy to preserve and improve the market leadership has always been built around establishing a successful partnership with our suppliers, through mutual business respect, understanding and a focus on customers鈥� needs.
